Alexandra Balcom

Chief Financial Officer

Alexandra Balcom (Chief Financial Officer) filed 12 Form 4 reports in the trailing twelve months (0 purchases, 12 sales), most often in Nuvalent Inc (NUVL). The largest single filing was $3.5M of NUVL (39,800 sh across 6 lots, as filed), executed Oct 13 2025.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 12 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$18.0M

shares × price, as filed

Last traded

Jul 1

Filed Jul 6

Median ADV $288.8M across their filed names

Open performance→

Volume by month

Buys $0 Sells $24.2M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 12 filings

Sector per market data · by filing · past 12 months

Most traded names

NUVL

Nuvalent Inc NUVL · 0 buys · 18 sells 18 filings

Recent filings

NUVLSALE Nuvalent Inc View filing → $1.4M
11,430 sh × $123.58
Exec Jul 1
Filed Jul 6 · 4:30 PM ET NUVLSALE Nuvalent Inc View filing → $900K
9,091 sh across 4 lots
Exec Jun 1
Filed Jun 3 · 5:30 PM ET NUVLSALE Nuvalent Inc View filing → $1.1M
11,306 sh across 2 lots
Exec May 1
Filed May 5 · 5:30 PM ET NUVLSALE Nuvalent Inc View filing → $1.2M
11,430 sh across 3 lots
Exec Apr 1
Filed Apr 3 · 5:30 PM ET NUVLSALE Nuvalent Inc View filing → $2.5M
25,130 sh across 4 lots
Exec Mar 24
Filed Mar 26 · 5:30 PM ET NUVLSALE Nuvalent Inc View filing → $584K
6,004 sh across 4 lots
Exec Jan 5
Filed Jan 7 · 5:30 PM ET NUVLSALE Nuvalent Inc View filing → $770K
6,984 sh × $110.31
Exec Dec 8 2025
Filed Dec 10 2025 · 5:30 PM ET NUVLSALE Nuvalent Inc View filing → $1.9M
19,620 sh across 5 lots
Exec Nov 17 2025
Filed Nov 19 2025 · 5:30 PM ET More filings →